Dr. Mark H Schoenfisch's lab focuses on developing innovative therapies to treat periodontal disease, a condition that causes inflammation and damage to the tissues supporting the teeth. The lab is working on creating a new type of treatment using hyaluronic acid that can release nitric oxide, which aims to fight harmful bacteria, reduce inflammation, and promote healing in the gums. Their research combines the fields of chemistry and biology to create effective, localized treatments for better oral and systemic health.

Dr. Matthew R. Redinbo's lab at the University of North Carolina Chapel Hill focuses on understanding how gut microbial enzymes affect human health and disease. Their research explores the roles of these enzymes in various conditions, including infections and chronic diseases like kidney and heart disease, by investigating their structures and functions. The lab employs advanced techniques to discover new ways to target these microbial proteins, with the goal of developing innovative diagnostics and therapeutics.

Dr. Sergei Sheiko's lab focuses on developing innovative materials for breast reconstruction surgery, aiming to create a new injectable platform that mimics the natural properties of human tissue. This technology seeks to reduce the health risks associated with current implants, improve the safety and aesthetic outcomes for patients, and ultimately enhance the quality of life for those affected by breast cancer. The lab's work also opens doors for advancements in other reconstructive surgeries.